REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024 |
FOR |
WORKING WITH CANCER |
REGISTERED NUMBER: |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024 |
FOR |
WORKING WITH CANCER |
WORKING WITH CANCER (REGISTERED NUMBER: 09092152) |
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 3 |
WORKING WITH CANCER |
COMPANY INFORMATION |
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024 |
DIRECTORS: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Ground Floor |
Egerton House |
68 Baker Street |
Weybridge |
Surrey |
KT13 8AL |
WORKING WITH CANCER (REGISTERED NUMBER: 09092152) |
BALANCE SHEET |
31 DECEMBER 2024 |
31.12.24 | 30.6.23 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 4 |
CURRENT ASSETS |
Debtors | 5 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 6 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
PROVISIONS FOR LIABILITIES | 7 |
NET ASSETS |
RESERVES |
Income and expenditure account | 8 |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the Board of Directors and authorised for issue on |
WORKING WITH CANCER (REGISTERED NUMBER: 09092152) |
NOTES TO THE FINANCIAL STATEMENTS |
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024 |
1. | STATUTORY INFORMATION |
Working With Cancer is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Turnover |
Turnover represents net invoiced sales of consultancy services, excluding Value Added Tax. Turnover is |
recognised in the period in which the services are provided. |
Tangible fixed assets |
Plant and machinery etc | - |
Taxation |
Taxation for the period comprises current. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the period was |
4. | TANGIBLE FIXED ASSETS |
Plant and |
machinery |
etc |
£ |
COST |
At 1 July 2023 |
Additions |
At 31 December 2024 |
DEPRECIATION |
At 1 July 2023 |
Charge for period |
At 31 December 2024 |
NET BOOK VALUE |
At 31 December 2024 |
At 30 June 2023 |
WORKING WITH CANCER (REGISTERED NUMBER: 09092152) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024 |
5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.12.24 | 30.6.23 |
£ | £ |
Trade debtors |
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.12.24 | 30.6.23 |
£ | £ |
Tax |
Social security and other taxes |
VAT | 3,390 | 7,442 |
Other creditors |
Directors' loan accounts | 6,281 | 6,781 |
Accrued expenses |
7. | PROVISIONS FOR LIABILITIES |
31.12.24 | 30.6.23 |
£ | £ |
Deferred tax | 186 | 94 |
Deferred |
tax |
£ |
Balance at 1 July 2023 |
Provided during period |
Balance at 31 December 2024 |
8. | RESERVES |
Income |
and |
expenditure |
account |
£ |
At 1 July 2023 |
Deficit for the period | ( |
) |
At 31 December 2024 |
9. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
The following loan from a director subsisted during the period ended 31 December 2024 and the year ended 30 June 2023: |
31.12.24 | 30.6.23 |
£ | £ |
Director |
Balance outstanding at start of period | (6,781 | ) | (6,781 | ) |
Amounts advanced | 709 | 102 |
Amounts repaid | (209 | ) | (102 | ) |
Amounts written off | - | - |
Amounts waived | - | - |
Balance outstanding at end of period | (6,281 | ) | (6,781 | ) |
WORKING WITH CANCER (REGISTERED NUMBER: 09092152) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE PERIOD 1 JULY 2023 TO 31 DECEMBER 2024 |
9. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES - continued |
This amount is interest free. |
10. | LIMITED BY GUARANTEE |
The company is a private company limited by guarantee and not having a share capital. |
The company has a not for profit status with an 'asset lock' which ensures that assets are used only for the benefit of the community. |